Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Other Non-Current Liabilities (2018 - 2026)

Viemed Healthcare filings provide 8 years of Other Non-Current Liabilities readings, the most recent being $922000.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 8.98% to $922000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $922000.0, a 8.98% increase, with the full-year FY2025 number at $922000.0, up 8.98% from a year prior.
  • Other Non-Current Liabilities hit $922000.0 in Q4 2025 for Viemed Healthcare, up from $680000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $1.7 million in Q1 2021 to a low of $385000.0 in Q2 2022.
  • Median Other Non-Current Liabilities over the past 5 years was $666000.0 (2024), compared with a mean of $704800.0.
  • Biggest five-year swings in Other Non-Current Liabilities: crashed 55.8% in 2022 and later skyrocketed 65.45% in 2023.
  • Viemed Healthcare's Other Non-Current Liabilities stood at $757000.0 in 2021, then rose by 17.44% to $889000.0 in 2022, then crashed by 37.23% to $558000.0 in 2023, then surged by 51.61% to $846000.0 in 2024, then grew by 8.98% to $922000.0 in 2025.
  • The last three reported values for Other Non-Current Liabilities were $922000.0 (Q4 2025), $680000.0 (Q3 2025), and $549000.0 (Q2 2025) per Business Quant data.